Lynn Baird, a veteran life sciences company executive, is the new vice president for regulatory, quality and clinical operations at , a developer of vaccine related technology.

Baird most recently was senior vice president for regulatory, quality and clinical operations at CombinatoRX in Cambridge, Ma. Baird also has worked at Dyax, Curis and CytoTherapeutics.

" We will look to Lynn to manage the regulatory affairs for in-house programs at AlphaVax as they move through clinical development, as well as coordinate and support regulatory activities of corporate partners involved with our alphavirus vector platform," said Andrew Graham, vice president of development at AlphaVax, in a statement.